Skip to main content
SpringerLink
Log in
Book cover

Head and Neck Cancer pp 255–265Cite as

Approaches to Supportive Care

  • Chapter
  • First Online:

  • 2528 Accesses

Abstract

Head and neck cancer is associated with ­substantial symptom and function loss. It is critical to understand the depth and breadth of issues face by patients in order to maximize quality of life. Symptoms and functional deficits may be secondary to either the cancer or its treatment. The mechanism of toxicity varies depending on the extent of tumor involvement, the site of tumor, treatment modality, and host factors. Toxicity is usually categorized as acute (occurring within 3 months of therapy) or late (occurring 3 months or after therapy). In addition, it is also important to distinguish local versus systemic toxicities. Although head and neck cancer therapy is associated with significant system effects, data pertaining to these toxicities are lacking. Thus, this chapter reviews the selected critical supportive care issues localized to the head and neck region. This includes: mucositis, nutrition, dysphagia, xerostomia and hyposalivation, oral health issues, and radiation dermatitis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Murphy BA, Ridner S, Wells N, Dietrich M. Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol. 2007;62:251–67.

    PubMed  Google Scholar 

  2. Murphy BA, Gilbert J, Ridner SH. Systemic and global toxicities of head and neck treatment. Expert Rev Anticancer Ther. 2007;7:1043–53.

    PubMed  Google Scholar 

  3. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199–210.

    PubMed  CAS  Google Scholar 

  4. Delanian S, Lefaix JL. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol. 2007;19:99–108.

    Google Scholar 

  5. Sonis S. The pathobiology of mucositis. Nat Rev. 2004;4:277–84.

    CAS  Google Scholar 

  6. Sonis S. Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol. 2007;5(9):3–11.

    PubMed  CAS  Google Scholar 

  7. Epstein JB et al. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer. 2007;109(9):1914–22.

    PubMed  Google Scholar 

  8. Vera-Llonch M, Oster G, Hagiwara M, et al. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer. 2006;106:329–36.

    PubMed  Google Scholar 

  9. Elting LS, Cooksley CD, Chambers MS, Garden A. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68:1110–20.

    PubMed  Google Scholar 

  10. Trotti A et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66(3):253–62.

    PubMed  Google Scholar 

  11. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol. 2003;39:91–100.

    PubMed  Google Scholar 

  12. Murphy B. Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. J Support Oncol. 2007;5(9):13–21.

    PubMed  Google Scholar 

  13. Wong PC, Dodd MJ, Miaskowski C, et al. Mucositis pain induced by radiation therapy: prevalence, severity, and use of self-care behaviors. J Pain Symptom Manage. 2006;32(1):27–37.

    PubMed  Google Scholar 

  14. Murphy BA, Chen A, Curran WJ, Garden AS, Harari PM, Wong SJ, et al. Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findings. Support Care Cancer. 2009;17(11):1393–401.

    PubMed  Google Scholar 

  15. Peterman A, Cella D, Glandon G, Dobrez D, Yount S. Mucositis in head and neck cancer: economic and quality-of-life outcomes. J Natl Cancer Inst. 2001;29:45–51.

    Google Scholar 

  16. Nonzee N, Dandade NA, Markossian T, Agulnik M, Argiris A, Patel J, et al. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis. Cancer. 2008;113:1446–52.

    PubMed  Google Scholar 

  17. Kendall K. Anatomy and physiology of deglutition. In: Kendall LA, editor. Dysphagia assessment and treatment planning. San Diego, CA: Plural Publishing; 2008. p. 27–34.

    Google Scholar 

  18. Murray T, Carrau RL, editors. Anatomy and function of the ­swallowing mechanism. In: Clinical management of swallowing disorders. San Diego, CA: Plural Publishing; 2006. p. 15–33.

    Google Scholar 

  19. Aviv J. The normal swallow. In: Murry CA, editor. Comprehensive management of swallowing disorders. San Diego, CA: Plural Publishing; 2006. p. 23–9.

    Google Scholar 

  20. Kendall K. Anatomy and physiology of deglutition. 2nd Edition. In: Kendall LA, editor. Dysphagia assessment and treatment planning. San Diego, CA: Plural Publishing; 2008. p. 1–26.

    Google Scholar 

  21. Goodrich SJ, Walker AI. Clinical swallow evaluation. In: Leonard R, Kendall K, editors. Dysphagia assessment and ­treatment planning. San Diego, CA: Plural Publishing; 2008. p. 103–14.

    Google Scholar 

  22. Murry T, Carrau RL, editors. Evaluation of dysphagia. In: Clinical management of swallowing disorders. San Diego, CA: Plural Publishing; 2006. p. 95–135.

    Google Scholar 

  23. Aviv JE, Murry T, Zschommler A, Cohen M, Gartner C. Flexible endoscopic evaluation of swallowing with sensory testing: patient characteristics and analysis of safety in 1, 340 consecutive examinations. Ann Otol Rhinol Laryngeal. 2005;114:173–6.

    Google Scholar 

  24. Cohen MA, Setzen M, Perlman PW, Ditkoff M, Mattucci K, Guss J. The safety of flexible endoscopic evaluation of swallowing with sensory testing in an outpatient otolaryngology setting. Laryngoscope. 2003;113:21–4.

    PubMed  Google Scholar 

  25. Logemann J, Bytell D. Swallowing disorders in three types of head and neck surgical patients. Cancer. 1979;44:1095–105.

    PubMed  CAS  Google Scholar 

  26. Logemann JA, Pauloski BR, Rademaker AW, et al. Speech and swallow function after tonsil/base of tongue resection. J Speech Hear Res. 1993;36:918–26.

    PubMed  CAS  Google Scholar 

  27. Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68(5):1289–98.

    PubMed  Google Scholar 

  28. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head and neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60(5):1425–39.

    PubMed  Google Scholar 

  29. Fua TF et al. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia. Int J Radiat Oncol Biol Phys. 2007;67(4):976–81.

    PubMed  Google Scholar 

  30. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66:253–62.

    PubMed  Google Scholar 

  31. Rosenthal DI, Lewin JS, Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol. 2006;24:2636–43.

    PubMed  Google Scholar 

  32. Laurell G et al. Stricture of the proximal esophagus in head and neck carcinoma patients after radiotherapy. Cancer. 2003;97(7):1693–700.

    PubMed  Google Scholar 

  33. Lawson JD, Otto K, Grist W, Johnstone P. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. Am J Otolaryngol. 2008;29:13–9.

    PubMed  Google Scholar 

  34. Ahlawate SK, Al-Kawas FH. Endoscopic management of upper esophageal strictures after treatment of head and neck malignancy. Gastrointest Endosc. 2008;68:19–24.

    Google Scholar 

  35. Nguyen NP, Moltz CC, Frank C, Vos P, Smith HJ, Karlsson U, et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol. 2004;15:383–8.

    PubMed  CAS  Google Scholar 

  36. Murry T, Carrau RL, editors. The abnormal swallow: conditions and diseases. In: Clinical management of swallowing disorders. San Diego, CA: Plural Publishing; 2006. p. 38–40.

    Google Scholar 

  37. Murphy BA, Friedman J, Dowling E, Cheatham R, Cmela A. Dietary intake and adaptations in head and neck cancer patients treated with chemoradiation. Proc Am Soc Clin Oncol. 2002;21:abstract # 932.

    Google Scholar 

  38. Pauloski BR et al. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck. 2002;24(6):555–65.

    PubMed  Google Scholar 

  39. Cheng S, Terrell JE, Bradford CR, Ronis DL, Fowler KE, Prince ME, et al. Variables associated with feeding tube placement in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132:655–61.

    PubMed  Google Scholar 

  40. Schueren, M.v.B.-d.v.d. Differences in immune status between well nourished and malnourished head and neck cancer patients. Clin Nutr 1998;17(3):107–11.

    Google Scholar 

  41. Brookes GB. Nutritional status-a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg. 1985;93:69–74.

    PubMed  CAS  Google Scholar 

  42. Schueren, M.v.B.-d.v.d. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer. 1999;86:519–27.

    Google Scholar 

  43. Newman LA et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 1998;124:589–92.

    PubMed  CAS  Google Scholar 

  44. Schueren, M.v.B.-d.v.d. The impact of nutritional status on the prognosis of patients with head and neck cancer. Cancer. 1999;86:519–27.

    Google Scholar 

  45. Hammerlid E et al. Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck. 1998;20:540–8.

    PubMed  CAS  Google Scholar 

  46. Colasanto JM, Prasad P, Nash MA, Decker RH, Wilson LD. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology. 2005;19(3):371–87.

    PubMed  Google Scholar 

  47. Minasian A, Dwyer JT. Nutritional implications of dental and swallowing issues in head and neck cancer. Oncology. 1998;12(8):1155–62.

    PubMed  CAS  Google Scholar 

  48. Harris JA, Benedict FG. A biometric study of basal metabolism in man. Publication 279. Washington, DC: Carnegie Institution; 1919. p. 40–4.

    Google Scholar 

  49. Gibson S, Wenig B. Percutaneous endoscopic gastrostomy in the management of head and neck carcinoma. Laryngoscope. 1992;102:977–81.

    PubMed  CAS  Google Scholar 

  50. Mekhail TM et al. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer. 2001;91(9):1785–90.

    PubMed  CAS  Google Scholar 

  51. Lin A, Jabbari S, Worden FP, Bradford CR, Chepeha DB, Teknos T, et al. Metabolic abnormalities associated with weight loss during chemoirradiation of head and neck cancer. Int J Radiat Biol Phys. 2005;63:1413–8.

    CAS  Google Scholar 

  52. Tyldesley S et al. The use of radiologically placed gastrostomy tubes in head and neck cancer patients receiving radiotherapy. Int J Radiat Oncol Biol Phys. 1996;36(5):1205–9.

    PubMed  CAS  Google Scholar 

  53. Beer KT, Krause KB, Zuercher T, Stanga Z. Early percutaneous endoscopic gastrostomy insertion maintains nutritional state in patients with aerodigestive tract cancer. Nutr Cancer. 2005;52(1):29–34.

    PubMed  Google Scholar 

  54. Bergstrom LR, Larson D, Zinsmeister AR, Sarr MG, Silverstein MD. Utilization and outcomes of surgical gastrostomies and jejunostomies in an era of percutaneous endoscopic gastrostomy: a population-based study. Mayo Clin Proc. 1995;70:829–36.

    PubMed  CAS  Google Scholar 

  55. Silver HJ, Wellman NS, Arnold DJ, Livingstone AS, Byers PM. Older adults on home enteral nutrition: enteral regimen, provider involvement, and health care outcomes. J Parenter Enteral Nutr. 2004;28:92–8.

    Google Scholar 

  56. Beecken L, Calaman F. A return to “Normal Eating” after curative treatment for oral cancer. Eur J Cancer B Oral Oncol. 1994;30B:387–92.

    Google Scholar 

  57. Morley JE, Thomas DR, Wilson MMG. Cachexia: ­pathophysiology and clinical relevance. Am J Clin Nutr. 2006;83:735–43.

    PubMed  CAS  Google Scholar 

  58. Innui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin. 2002;52:72–91.

    Google Scholar 

  59. Tisdale M. Metabolic alterations in cachexia and anorexia. Nutrition. 2000;16:1013–4.

    PubMed  CAS  Google Scholar 

  60. Davis MP, Dreicer R, Walsh D, Lagman R, LeGrand SB. Appetite and cancer-associated anorexia: a review. J Clin Oncol. 2004;22(8):1510–7.

    PubMed  CAS  Google Scholar 

  61. Desport JD, Gory-Delabaere G, Blanc-Vincent MP, et al. Standards, options and recommendations for the use of appetite stimulants in oncology 2000. Br J Cancer. 2003;89:S98–100.

    PubMed  Google Scholar 

  62. Chen H. Effect of megestrol acetate and prepulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy. Radiother Oncol. 1997;43(1):75–9.

    PubMed  CAS  Google Scholar 

  63. Duncan GG, Epstein JB, Tu D, et al. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck. 2005;27(5):421–8.

    PubMed  Google Scholar 

  64. Henson BS, Inglehart MR, Eisbruch A, Ship JA. Preserved salivary output and xerostomia-related quality-of-life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol. 2001;37(1):84–93.

    PubMed  CAS  Google Scholar 

  65. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head and neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003;57(12):61–70.

    PubMed  Google Scholar 

  66. Hand A. Salivary glands. In: Cate T, editor. Oral histology. Montreal: Mosby Elsevier; 2008. p. 290–1.

    Google Scholar 

  67. Mandel DD. The role of saliva in maintaining oral homeostasis. JADA. 1989;119:298–304.

    PubMed  CAS  Google Scholar 

  68. Backstrom I, Funegard U, Andersson I, Franzen L, Johansson I. Dietary intake in head and neck irradiated patients with permanent dry mouth symptoms. Eur J Cancer B Oral Oncol. 1995;31B(4):253–7.

    PubMed  CAS  Google Scholar 

  69. Rhodus NL, Moller K, Colby S, Bereuter J. Articulatory speech performance in patients with salivary gland dysfunction: a pilot study. Quintessence Int. 1995;26:805–10.

    PubMed  CAS  Google Scholar 

  70. Rho GJ et al. Influence of in vitro oxygen concentrations on preimplantation embryo development, gene expression and production of Hanwoo calves following embryo transfer. Mol Reprod Dev. 2007;74(4):486–96.

    PubMed  CAS  Google Scholar 

  71. Logemann J et al. Effects of xerostomia on perception and performance of swallow function. Head Neck. 2001;23:317–21.

    PubMed  CAS  Google Scholar 

  72. Hamlet S et al. Mastication and swallowing in patients with postirradiation xerostomia. Int J Radiation Biol Phys. 1997;37:789–96.

    CAS  Google Scholar 

  73. Frazen L et al. Parotid gland function during and following radiotherapy of malignancies in the head and neck. Br J Cancer. 1992;28:457–62.

    Google Scholar 

  74. Eisbruch A, TenHaken RK, Kin HM, March LH, Ship JA. Dose, volume, and function relationships in parotic salivary glands following conformal and intensity-modulated irradiation of the head and neck cancer. Int J Radiation Biol Phys. 1999;45:577–87.

    CAS  Google Scholar 

  75. Jha N et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol. 2003;66(3):283–9.

    PubMed  Google Scholar 

  76. Sasse AD, Clark LG, Sasse EC, Alark ACC. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int J Radiat Oncol Biol Phys. 2005;64(1):784–91.

    PubMed  Google Scholar 

  77. Rudat V, Meyer J, Momm F, Bendel M, Henke M, Strnad V, et al. Protective effect of amifostine on dental health after radiotherapy of the head and neck. Int J Radiat Oncol Biol Phys. 2000;48(5):1339–43.

    PubMed  CAS  Google Scholar 

  78. Wasserman T, Mackowiak JI, Brizel DM, Oster W, Zhang J, Peeples PJ, et al. Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;48(4):1035–9.

    PubMed  CAS  Google Scholar 

  79. Bardet E, Martin L, Calais G, Alfonsi M, Feham N, Tuchais C, et al. Subcutaneous versus intravenous administration of amifostine for head and neck cancer patients receiving radiotherapy: preliminary results of the GORTEC 2000-02 randomized trial. Int J Radiat Oncol Biol Phys. 2005;63(2):S127.

    Google Scholar 

  80. Brosky M. The role of saliva in oral health: strategies for prevention and management of xerostomia. J Support Oncol. 2007;5:215–25.

    PubMed  CAS  Google Scholar 

  81. Scarantino C et al. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. J Support Oncol. 2006;4(5):252–8.

    PubMed  CAS  Google Scholar 

  82. Kam MKM, Leung SF, Zee B, Chau R, Suen JJS, Mo F, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007;25(31):4873–9.

    PubMed  Google Scholar 

  83. Chao KS et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol. 2001;61(3):275–80.

    PubMed  CAS  Google Scholar 

  84. Daly ME, Lieskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, et al. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for squamous cell head and neck cancer. Head Neck. 2007;29:211–20.

    PubMed  Google Scholar 

  85. Saarilahti K, Kouri M, Collan J, Kangasmaki A, Atula T, Joensuu H, et al. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiat Oncol. 2006;73:320–5.

    Google Scholar 

  86. Johnson JT et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med. 1993;329:390–5.

    PubMed  CAS  Google Scholar 

  87. Chambers MS et al. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68(4):1102–9.

    PubMed  CAS  Google Scholar 

  88. Oral health in cancer therapy: a guide for health care professionals. www.doep.org

  89. Keck T, Rozsasi A, Leiacker R, Scheithauer MO. Lower airway humidification in spontaneously breathing tracheostomized patients: comparative study of trachea spray versus heated humidification. Head Neck. 2008;30:582–8.

    PubMed  Google Scholar 

  90. Dreizen S, Brown LR, Daly TE, Drane BE. Prevention of xerostomia-related dental caries in irradiated cancer patients. J Dent Res. 1977;56(2):99–104.

    PubMed  CAS  Google Scholar 

  91. Papas A et al. Caries clinical trial of a remineralising toothpaste in radiation patients. Gerodontology. 2008;25(2):76–88.

    PubMed  Google Scholar 

  92. Bomeli SR, Desai S, Johnson JT. Management of salivary flow in head and neck patients. Oral Oncol. 2008;44:1000–8.

    PubMed  Google Scholar 

  93. Dijkstra PU, Huisman PM, Roodenburg JLN. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg. 2006;35:337–42.

    PubMed  CAS  Google Scholar 

  94. Teguh DN, Levendag PC, Voet P, van der Est H, Noever I, de Kruijf W, et al. Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus. Head Neck. 2008;30:622–30.

    PubMed  Google Scholar 

  95. Dijkstra PU, Kalk WWI, Roodenburg JLN. Trismus in head and neck oncology: a systematic review. Oral Oncol. 2004;40(9):879–89.

    PubMed  CAS  Google Scholar 

  96. Kent ML, Bennan MT, Noll JL, Fox PC, Burri SH, Hunter JC, et al. Radiation-induced trismus in head and neck cancer patients. Support Care Cancer. 2008;16:305–9.

    Google Scholar 

  97. Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY. The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope. 2005;115:1458–60.

    PubMed  Google Scholar 

  98. Chua D, Lo C, Yuen J, Foo YC. A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol. 2001;24(4):366–9.

    PubMed  CAS  Google Scholar 

  99. Hartl DM, Cohen M, Julieron M, Marandas P, Janot F, Bourhis J. Botulinum toxin for radiation-induced facial pain and trismus. Otolaryngol Head Neck Surg. 2008;138:459–63.

    PubMed  Google Scholar 

  100. Dijkstra PU, Sterken MW, Pater R, Spijkervet FKL, Roodenburg JLN. Exercise therapy for trismus in head and neck cancer. Oral Oncol. 2007;43:389–94.

    PubMed  CAS  Google Scholar 

  101. Finnerup NB, Jensen TS. Mechanisms of disease: mechanism-based classification of neuropathic pain – a critical analysis. Nat Clin Pract Neurol. 2006;2(2):107–15.

    PubMed  Google Scholar 

  102. Bonner JA, Ang K. More on severe cutaneous reaction with radiotherapy and cetuximab. N Engl J Med. 2007;357:1872–3.

    PubMed  Google Scholar 

  103. Budach W, Bölke E, Horney B. Severe cutaneous reaction during radiation therapy with concurrent cetuximab. N Engl J Med. 2007;367(21):514–5.

    Google Scholar 

  104. Sitton E. Early and late radiation-induced skin alterations part 1: mechanism of skin changes. Oncology Nursing Forum. 1992;19(5):801.

    PubMed  CAS  Google Scholar 

  105. Blackmar A. Radiation-induced skin alterations. Medsurg Nursing. 1997;6(3):172–5.

    PubMed  CAS  Google Scholar 

  106. Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol. 2006;54(1):28–46.

    PubMed  Google Scholar 

  107. Stohl R. The nursing role in radiation oncology: symptom management of acute and chronic reactions. Oncol Nurs Forum. 1988;15(4):429–34.

    Google Scholar 

  108. D’haessse S, Bate T, Claes S, Boone A, Vanvoorden V, Efficace F. Management of skin reactions during radiotherapy: a study of nursing practice. Eur J Cancer Care. 2005;14:28–42.

    Google Scholar 

  109. Bernier J et al. Consensus guidelines for the management of ­radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol. 2008;19:142–9.

    PubMed  CAS  Google Scholar 

  110. World Health Organization. A handbook for reporting results of cancer treatment. Geneva: World Health Organization; 1979.

    Google Scholar 

  111. Trotti A et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13(3):176–81.

    PubMed  Google Scholar 

  112. American Speech-Language-Hearing Association. Roles of speech-language pathologists in swallowing and feeding disorders: technical report [Technical Report]. 2001. Available from www.asha.org.

  113. Molseed L. Clinical evaluation of swallowing: the nutritionist’s perspective. In: Murry CA, editor. Comprehensive management of swallowing disorders. San Diego, CA: Plural Publishing; 2006. p. 59.

    Google Scholar 

  114. Blackburn GL, Bistrian BR, Miani BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. J Parenter Enteral Nutr. 1977;1:11–22.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pain and Symptom Management Program, Internal Medicine, Vanderbilt Ingram Cancer Center, 777 Preston Research Blvd, Nashville, TN, 37215, USA

    Barbara A. Murphy

Authors
  1. Barbara A. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara A. Murphy .

Editor information

Editors and Affiliations

  1. , Dept of Radio-Oncology, Genolier Swiss Medical Network, 4 Route du Muids, Genolier, CH-1272, Switzerland

    Jacques Bernier

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Murphy, B.A. (2011). Approaches to Supportive Care. In: Bernier, J. (eds) Head and Neck Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9464-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9464-6_17

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-9463-9

  • Online ISBN: 978-1-4419-9464-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation